Associated Papers
Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.
Mondejar R et al.
Plos One, 2017
28505169 (PubMed )
Supplement: pone.0177524.s006.xlsx › Supplementary_table_6
Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels.
Guillaumet-Adkins A et al.
Journal of Hematology & Oncology, 2014
Select a paper to view details